Purpose of Review
Autism Spectrum Disorders (ASD) are heterogeneous neurodevelopmental disorders associated with various co-morbidities. Neurological co-morbidities include motor impairments, epilepsy and sleep dysfunction. These impairments are receiving more attention recently, perhaps because of their significant impact on the behavior and cognitive function of children with ASD. Here, we review the epidemiology, etiology and clinical approach to these neurological co-morbidities and highlight future research directions.
Recent Findings
Motor impairments include stereotypies, motor delays and deficits, such as dyspraxia, incoordination and gait problems. Sleep dysfunction typically presents as difficulty with sleep onset and prolonged awakenings during the night. Recent data suggest that abnormalities in melatonin may affect sleep and may be a potential treatment target. There is no classic epilepsy syndrome associated with ASD. Intellectual disability, syndromic autism and female gender are specific risk factors. Recent research has focused on identifying the overlapping pathways between these neurological co-morbidities and the core deficits in ASD, which may have direct and powerful implications for treatment and prognosis.
Summary
Motor impairment, epilepsy and sleep dysfunction are common neurological co-morbidities in ASD. Clinicians should be aware that recognition and treatment of these issues may improve the function and outcome of children with ASD.